165 related articles for article (PubMed ID: 26361658)
1. p-Cresol and Cardiovascular Risk in Kidney Transplant Recipients.
Ligabue G; Damiano F; Cuoghi A; De Biasi S; Bellei E; Granito M; Aldo T; Cossarizza A; Cappelli G
Transplant Proc; 2015 Sep; 47(7):2121-5. PubMed ID: 26361658
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
[TBL] [Abstract][Full Text] [Related]
3. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
[TBL] [Abstract][Full Text] [Related]
5. Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results.
Cheddani L; Liabeuf S; Essig M; Snanoudj R; Jacquelinet C; Kerleau C; Metzger M; Balkau B; Drüeke TB; Hourmant M; Massy ZA;
Nephrol Dial Transplant; 2021 Jan; 36(1):176-184. PubMed ID: 32162656
[TBL] [Abstract][Full Text] [Related]
6. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY
Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
8. Quantification of p-cresol sulphate in human plasma by selected reaction monitoring.
Cuoghi A; Caiazzo M; Bellei E; Monari E; Bergamini S; Palladino G; Ozben T; Tomasi A
Anal Bioanal Chem; 2012 Oct; 404(6-7):2097-104. PubMed ID: 22868475
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
[TBL] [Abstract][Full Text] [Related]
10. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
[TBL] [Abstract][Full Text] [Related]
11. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
13. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS.
Lin CN; Wu IW; Huang YF; Peng SY; Huang YC; Ning HC
J Food Drug Anal; 2019 Apr; 27(2):502-509. PubMed ID: 30987721
[TBL] [Abstract][Full Text] [Related]
14. A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
Boelaert J; Lynen F; Glorieux G; Eloot S; Van Landschoot M; Waterloos MA; Sandra P; Vanholder R
Anal Bioanal Chem; 2013 Feb; 405(6):1937-47. PubMed ID: 23307120
[TBL] [Abstract][Full Text] [Related]
15. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
[TBL] [Abstract][Full Text] [Related]
16. Bowel Habits and the Association With Uremic Toxins in Non-Dialysis-Dependent Chronic Kidney Disease Patients.
Ramos CI; Armani RG; Canziani ME; Ribeiro Dolenga CJ; Nakao LS; Campbell KL; Cuppari L
J Ren Nutr; 2020 Jan; 30(1):31-35. PubMed ID: 30956092
[TBL] [Abstract][Full Text] [Related]
17. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
[TBL] [Abstract][Full Text] [Related]
18. Uremic toxin development in living kidney donors: a longitudinal study.
Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM
Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249
[TBL] [Abstract][Full Text] [Related]
19. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease.
Krishnasamy R; Hawley CM; Stanton T; Pascoe EM; Campbell KL; Rossi M; Petchey W; Tan KS; Beetham KS; Coombes JS; Leano R; Haluska BA; Isbel NM
BMC Nephrol; 2015 Jul; 16():106. PubMed ID: 26187506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
